The availability of targeted anticancer drugs and the relative affordability of genomic analyses has led to a growing expectation among patients with cancer that they can receive personalized treatment based on the genomic signature of their tumour. Here, we discuss some of the challenges and steps needed to bring such approaches into routine practice.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/nrd.2017.218 | DOI Listing |
Publication Analysis
Top Keywords
steps forward
4
forward cancer
4
cancer precision
4
precision medicine
4
medicine availability
4
availability targeted
4
targeted anticancer
4
anticancer drugs
4
drugs relative
4
relative affordability
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!